Levetiracetam Ametas

Levetiracetam, the active ingredient in Levetiracetam Ametas, is an antiepileptic presented as an oral formulation for oral administration. It is indicated for the treatment of epilepsy, specifically partial seizures and generalized tonic‑clonic seizures, and is used in both adult and pediatric populations under medical supervision.

GNH USA supplies Levetiracetam Ametas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution with comprehensive regulatory documentation and support for import procedures.

Levetiracetam is an antiepileptic medication used to control abnormal neuronal activity in seizure disorders.

Epilepsy: reduces the frequency of seizures in patients with various epilepsy syndromes. Partial seizures: provides seizure control for focal onset seizures, with or without secondary generalization. Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with primary generalized epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Somnolence - Fatigue - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions such as Stevens‑Johnson syndrome - Mood changes including depression or suicidal thoughts - Severe skin rash - Hematologic abnormalities - Multi‑organ hypersensitivity - Rare hepatic dysfunction

Levetiracetam should be used with caution in certain clinical situations.

Renal impairment: dose adjustment may be required in patients with reduced kidney function. Hepatic dysfunction: monitor liver enzymes in patients with liver disease. Psychiatric effects: observe for mood changes, depression, or aggression. Pregnancy: category B, use only if benefit outweighs risk. Drug interactions: review concomitant medications for potential interactions. Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and light.

Levetiracetam may interact with other medicines; some interactions require avoidance while others need monitoring.

Major Interactions (Avoid): - Concomitant use with carbamazepine: may reduce levetiracetam levels. - Co‑administration with enzyme‑inducing antiepileptics (e.g., phenobarbital, phenytoin): may decrease efficacy. - Use with strong CYP3A4 inhibitors (e.g., ritonavir): may increase plasma concentrations.

Moderate Interactions (Monitor Closely): - Combination with other CNS depressants (e.g., benzodiazepines): may enhance sedation. - Concurrent use with anticoagulants (e.g., warfarin): monitor INR. - Interaction with oral contraceptives: may reduce contraceptive effectiveness.